DE60135232D1 - Nukleinsäure und korrespondierendes protein 85p1b3, nützlich zur behandlung und detektion von krebserkrankungen - Google Patents
Nukleinsäure und korrespondierendes protein 85p1b3, nützlich zur behandlung und detektion von krebserkrankungenInfo
- Publication number
- DE60135232D1 DE60135232D1 DE60135232T DE60135232T DE60135232D1 DE 60135232 D1 DE60135232 D1 DE 60135232D1 DE 60135232 T DE60135232 T DE 60135232T DE 60135232 T DE60135232 T DE 60135232T DE 60135232 D1 DE60135232 D1 DE 60135232D1
- Authority
- DE
- Germany
- Prior art keywords
- useful
- detection
- treatment
- nucleic acid
- corresponding protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 5
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 201000011510 cancer Diseases 0.000 title 1
- 238000001514 detection method Methods 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 239000012634 fragment Substances 0.000 abstract 2
- 230000028993 immune response Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22843200P | 2000-08-28 | 2000-08-28 | |
PCT/US2001/026838 WO2002018578A2 (en) | 2000-08-28 | 2001-08-28 | Nucleic acid and corresponding protein entitled 85p1b3 useful in treatment and detection of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60135232D1 true DE60135232D1 (de) | 2008-09-18 |
Family
ID=22857145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60135232T Expired - Lifetime DE60135232D1 (de) | 2000-08-28 | 2001-08-28 | Nukleinsäure und korrespondierendes protein 85p1b3, nützlich zur behandlung und detektion von krebserkrankungen |
Country Status (11)
Country | Link |
---|---|
US (3) | US7217799B2 (de) |
EP (2) | EP2022797A3 (de) |
AT (1) | ATE403716T1 (de) |
AU (3) | AU2001288466B2 (de) |
CA (2) | CA2420990C (de) |
CY (1) | CY1109029T1 (de) |
DE (1) | DE60135232D1 (de) |
DK (1) | DK1313850T3 (de) |
ES (1) | ES2311540T3 (de) |
PT (1) | PT1313850E (de) |
WO (1) | WO2002018578A2 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2022797A3 (de) | 2000-08-28 | 2011-11-09 | Agensys, Inc. | Nukleinsäure und entsprechendes Protein mit der Bezeichnung 85P1B3 für die Behandlung und den Nachweis von Krebs |
JP2008537874A (ja) * | 2004-09-27 | 2008-10-02 | セントカー・インコーポレーテツド | sRAGEミメティボディ、組成物、方法および使用 |
WO2010023864A1 (en) * | 2008-08-28 | 2010-03-04 | Oncotherapy Science, Inc. | Oip5 as a target gene for cancer therapy and diagnosis |
US8449512B2 (en) | 2010-04-09 | 2013-05-28 | Davinci Biomedical Research Products Inc. | Stoma stabilitating device and method |
CN114195861A (zh) * | 2022-01-05 | 2022-03-18 | 许昌学院 | 亲和肽 |
Family Cites Families (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
JPS6023084B2 (ja) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
US4722848A (en) | 1982-12-08 | 1988-02-02 | Health Research, Incorporated | Method for immunizing animals with synthetically modified vaccinia virus |
US4870009A (en) | 1982-11-22 | 1989-09-26 | The Salk Institute For Biological Studies | Method of obtaining gene product through the generation of transgenic animals |
US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
US4736866B1 (en) | 1984-06-22 | 1988-04-12 | Transgenic non-human mammals | |
US5019369A (en) | 1984-10-22 | 1991-05-28 | Vestar, Inc. | Method of targeting tumors in humans |
DE3675588D1 (de) | 1985-06-19 | 1990-12-20 | Ajinomoto Kk | Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist. |
US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
GB8724885D0 (en) | 1987-10-23 | 1987-11-25 | Binns M M | Fowlpox virus promotors |
US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
US5225538A (en) | 1989-02-23 | 1993-07-06 | Genentech, Inc. | Lymphocyte homing receptor/immunoglobulin fusion proteins |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
ATE157012T1 (de) | 1989-11-03 | 1997-09-15 | Univ Vanderbilt | Verfahren zur in vivo-verabreichung von funktionsfähigen fremden genen |
US6150584A (en) | 1990-01-12 | 2000-11-21 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
EP0463151B1 (de) | 1990-01-12 | 1996-06-12 | Cell Genesys, Inc. | Erzeugung xenogener antikörper |
US6673986B1 (en) | 1990-01-12 | 2004-01-06 | Abgenix, Inc. | Generation of xenogeneic antibodies |
US5279833A (en) | 1990-04-04 | 1994-01-18 | Yale University | Liposomal transfection of nucleic acids into animal cells |
US5204253A (en) | 1990-05-29 | 1993-04-20 | E. I. Du Pont De Nemours And Company | Method and apparatus for introducing biological substances into living cells |
US5723286A (en) | 1990-06-20 | 1998-03-03 | Affymax Technologies N.V. | Peptide library and screening systems |
ES2264239T3 (es) | 1990-06-27 | 2006-12-16 | Princeton University | Complejo de proteinas p53/p90'. |
SE9002480D0 (sv) | 1990-07-23 | 1990-07-23 | Hans Lilja | Assay of free and complexed prostate-specific antigen |
US5733731A (en) | 1991-10-16 | 1998-03-31 | Affymax Technologies N.V. | Peptide library and screening method |
WO1993024640A2 (en) | 1992-06-04 | 1993-12-09 | The Regents Of The University Of California | Methods and compositions for in vivo gene therapy |
CA2141960A1 (en) | 1992-08-07 | 1994-02-17 | Ralph T. Kubo | Hla binding peptides and their uses |
US5489525A (en) * | 1992-10-08 | 1996-02-06 | The United States Of America As Represented By The Department Of Health And Human Services | Monoclonal antibodies to prostate cells |
CA2157510A1 (en) | 1993-03-05 | 1994-09-15 | Howard M. Grey | Hla-a2.1 binding peptides and their uses |
US5837501A (en) | 1993-07-09 | 1998-11-17 | Akzo Nobel N.V. | Nucleic acid quantitation by co-amplification of target with multiple internal controls |
US5679647A (en) | 1993-08-26 | 1997-10-21 | The Regents Of The University Of California | Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
US5804566A (en) | 1993-08-26 | 1998-09-08 | The Regents Of The University Of California | Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides |
AU698962B2 (en) | 1993-09-14 | 1998-11-12 | Epimmune, Inc. | Alteration of immune response using pan DR-binding peptides |
CH686982A5 (fr) | 1993-12-16 | 1996-08-15 | Maurice Stroun | Méthode pour le diagnostic de cancers. |
US5739118A (en) | 1994-04-01 | 1998-04-14 | Apollon, Inc. | Compositions and methods for delivery of genetic material |
ES2210306T3 (es) | 1994-07-20 | 2004-07-01 | The General Hospital Corporation | Sistemas de trampa para interacciones, para detectar interacciones de proteinas. |
US5919652A (en) | 1994-11-09 | 1999-07-06 | The Regents Of The University Of California | Nucleic acid molecules comprising the prostate specific antigen (PSA) promoter and uses thereof |
US5736524A (en) | 1994-11-14 | 1998-04-07 | Merck & Co.,. Inc. | Polynucleotide tuberculosis vaccine |
US5962428A (en) | 1995-03-30 | 1999-10-05 | Apollon, Inc. | Compositions and methods for delivery of genetic material |
NZ306767A (en) | 1995-04-11 | 2000-03-27 | Univ Johns Hopkins | Method of identifying molecular interactions employing counterselection and at least two hybrid molecules or two hybrid systems |
US5922687A (en) | 1995-05-04 | 1999-07-13 | Board Of Trustees Of The Leland Stanford Junior University | Intracellular delivery of nucleic acids using pressure |
CU22559A1 (es) | 1996-01-17 | 1999-05-03 | Ct Ingenieria Genetica Biotech | Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión |
BR9708161A (pt) | 1996-03-11 | 1999-07-27 | Epimmune Inc | Peptídeos com aumentada afinidade de ligação para moléculas hla |
DE69715621T2 (de) | 1996-04-26 | 2003-05-22 | Massachusetts Institute Of Technology, Cambridge | Drei hybriden screening test |
EP0960204A4 (de) | 1996-07-26 | 2002-01-23 | Sloan Kettering Inst Cancer | Methoden und reagenzien zur genetischen immunisierung |
US5925523A (en) | 1996-08-23 | 1999-07-20 | President & Fellows Of Harvard College | Intraction trap assay, reagents and uses thereof |
EP0953039B1 (de) | 1996-10-15 | 2007-08-29 | The Regents Of The University Of California | Tiermodelle für die menschliche prostatakrebsfortschreitung |
US5846722A (en) | 1996-10-16 | 1998-12-08 | Terrapin Technologies, Inc. | System to detect small molecule/peptide interaction |
US5840501A (en) | 1996-10-25 | 1998-11-24 | Bayer Corporation | Determination of cPSA |
EP1500329B1 (de) | 1996-12-03 | 2012-03-21 | Amgen Fremont Inc. | Menschliche Antikörper, die ausdrücklich menschliches TNF Alpha binden |
US6261791B1 (en) * | 1997-03-10 | 2001-07-17 | The Regents Of The University Of California | Method for diagnosing cancer using specific PSCA antibodies |
JP2001519667A (ja) | 1997-04-10 | 2001-10-23 | ジェネティックス・インスチチュート・インコーポレーテッド | 分泌発現配列タグ(sESTs) |
CA2402563A1 (en) * | 1999-12-23 | 2001-07-26 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
CA2395816A1 (en) | 2000-01-31 | 2001-08-02 | Human Genome Sciences, Inc. | Nucleic acids, proteins and antibodies |
EP1305450A2 (de) | 2000-07-28 | 2003-05-02 | Compugen Inc. | Oligonukleotidbibliothek für die detektion der rna-transkripten und splicevarianten eines transkriptoms |
GB0031021D0 (en) | 2000-07-31 | 2001-01-31 | Aventis Pharma Ltd | Polynucleotides and polypeptides |
EP2022797A3 (de) | 2000-08-28 | 2011-11-09 | Agensys, Inc. | Nukleinsäure und entsprechendes Protein mit der Bezeichnung 85P1B3 für die Behandlung und den Nachweis von Krebs |
-
2001
- 2001-08-28 EP EP08161748A patent/EP2022797A3/de not_active Withdrawn
- 2001-08-28 AT AT01968204T patent/ATE403716T1/de active
- 2001-08-28 AU AU2001288466A patent/AU2001288466B2/en not_active Ceased
- 2001-08-28 CA CA2420990A patent/CA2420990C/en not_active Expired - Fee Related
- 2001-08-28 WO PCT/US2001/026838 patent/WO2002018578A2/en active IP Right Grant
- 2001-08-28 ES ES01968204T patent/ES2311540T3/es not_active Expired - Lifetime
- 2001-08-28 EP EP01968204A patent/EP1313850B1/de not_active Expired - Lifetime
- 2001-08-28 AU AU8846601A patent/AU8846601A/xx active Pending
- 2001-08-28 CA CA2705366A patent/CA2705366A1/en not_active Abandoned
- 2001-08-28 DE DE60135232T patent/DE60135232D1/de not_active Expired - Lifetime
- 2001-08-28 DK DK01968204T patent/DK1313850T3/da active
- 2001-08-28 US US09/942,052 patent/US7217799B2/en not_active Expired - Fee Related
- 2001-08-28 PT PT01968204T patent/PT1313850E/pt unknown
-
2006
- 2006-07-19 US US11/489,907 patent/US7501502B2/en not_active Expired - Fee Related
-
2007
- 2007-06-27 AU AU2007202977A patent/AU2007202977B2/en not_active Ceased
-
2008
- 2008-11-04 CY CY20081101252T patent/CY1109029T1/el unknown
-
2009
- 2009-01-23 US US12/359,203 patent/US8173381B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20030170626A1 (en) | 2003-09-11 |
EP2022797A3 (de) | 2011-11-09 |
PT1313850E (pt) | 2008-11-18 |
EP2022797A2 (de) | 2009-02-11 |
AU2001288466B9 (en) | 2002-03-13 |
ES2311540T3 (es) | 2009-02-16 |
CY1109029T1 (el) | 2014-07-02 |
WO2002018578A3 (en) | 2002-10-03 |
AU2007202977B2 (en) | 2010-06-03 |
ATE403716T1 (de) | 2008-08-15 |
CA2420990C (en) | 2010-08-17 |
WO2002018578A2 (en) | 2002-03-07 |
CA2420990A1 (en) | 2002-03-07 |
US7501502B2 (en) | 2009-03-10 |
CA2705366A1 (en) | 2002-03-07 |
US7217799B2 (en) | 2007-05-15 |
DK1313850T3 (da) | 2008-12-01 |
EP1313850B1 (de) | 2008-08-06 |
US20090203016A1 (en) | 2009-08-13 |
AU2001288466B2 (en) | 2007-03-29 |
AU2007202977A1 (en) | 2007-07-19 |
EP1313850A2 (de) | 2003-05-28 |
AU8846601A (en) | 2002-03-13 |
US20070036762A1 (en) | 2007-02-15 |
US8173381B2 (en) | 2012-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1110876A1 (en) | Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers | |
MXPA02011656A (es) | Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos. | |
MY155218A (en) | Small molecules useful in the treatment of inflammatory disease | |
ATE326525T1 (de) | Bifidobakterium zur behandlung von entzündungskrankheiten | |
DE69733968D1 (de) | Norbornen- und norbornandiolen zur behandlung von pigmentierungsstörungen, neurodegenerativen erkrankungen oder proliferativen hauterkrankungen | |
FI852626A0 (fi) | Menetelmä ihmisen tuumorinekroositekijän valmistamiseksi ja sitä koodaava DNA | |
IL85411A0 (en) | Methods and deoxyribonucleic acid for the preparation of tissue factor protein | |
DE3856180D1 (de) | Nukleinsaürefragmente, die mannose bindende fragmente vom menschlichen mannosebindenden protein kodieren | |
EP1706423B8 (de) | Therapeutische und diagnostische anti-hsp 70-antikörper | |
DE60135232D1 (de) | Nukleinsäure und korrespondierendes protein 85p1b3, nützlich zur behandlung und detektion von krebserkrankungen | |
WO2002014361A3 (en) | NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 83P2H3 AND CaTrF2E11 USEFUL IN TREATMENT AND DETECTION OF CANCER | |
WO2004072263A3 (en) | Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers | |
ATE512216T1 (de) | Nukleinsäure und dieser entsprechendes, 184p1e2 genanntes, für die behandlung und den nachweis von krebs geeignetes protein | |
WO2003080800A3 (en) | Prevention and treatment of disease using angiogenesis-and/or tumor antigens | |
DE60139150D1 (de) | Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs | |
WO2002014501A3 (en) | Nucleic acids and corresponding proteins entitled phor1-a11 and phor1-f5d6 useful in treatment and detection of cancer | |
ATE501255T1 (de) | 84p2a9: prostata- und hodenspezifisches protein, das sehr stark bei prostatakrebs vorkommt | |
TR199901385T2 (xx) | Piperidin t�revleri. | |
WO2003020954A3 (en) | 205p1b5 in treatment and detection of cancer | |
DE60224778D1 (de) | Zusammensetzungen und Verfahren zur Behandlung und zur Detektion von proliferativen Störungen die mit der Überexpression des menschlichen "Transketolase like-1" gens in Zusammenhang stehen | |
WO2002088380A3 (en) | Immunogenic tumor antigens: nucleic acids and polypeptides encoding the same and methods of use thereof | |
DE60230051D1 (de) | Nukleinsäure und entsprechendes protein mit der bezeichnung 121p2a3 zur behandlung und zum nachweis von krebs | |
MXPA03010739A (es) | Moleculas de marcador endotelial tumoral 7-alfa y uso de las mismas. | |
FR2792639B1 (fr) | Nouveaux immunogenes anti-vih (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida | |
ATE65543T1 (de) | Dna-sequenzen des ebv-genoms, rekombinante dnamolek¨le, verfahren zur herstellung von ebvverwandten antigenen sowie diagnostische zusammensetzungen und pharmazeutische zusammensetzungen, die die genannten antigene enthalten. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8339 | Ceased/non-payment of the annual fee | ||
8370 | Indication related to discontinuation of the patent is to be deleted | ||
8364 | No opposition during term of opposition |